Status:
COMPLETED
Heparin Antagonization by Protamine in Cardiac Surgery: Pharmacokinetic/Pharmacodynamic Study
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Cardiac Surgery Requiring Extracorporeal Circulation
Eligibility:
All Genders
18+ years
Brief Summary
Protamine is currently used during cardiac surgery to neutralize unfractionated heparin (UFH) at the end of extra-corporeal circulation (ECC). The optimal dose of protamine is currently unknown, and t...
Eligibility Criteria
Inclusion
- Patients benefiting from scheduled or emergency at the Saint-Etienne University Hospital (coronary artery bypass grafting, valve replacements, aortic dissections).
Exclusion
- Patients with a contraindication to UFH
- Patients with a contraindication to protamine
- Patients requiring early resurgery.
- Patients receiving an injection of antithrombin III.
- Pregnant women.
- Patient for whom aprotinin use is planned during surgery.
Key Trial Info
Start Date :
November 13 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 12 2021
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04092868
Start Date
November 13 2019
End Date
March 12 2021
Last Update
March 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Saint-Etienne
Saint-Etienne, France, 42055